PALABA SLANÝ, PALABA, Největší objemy, RM Systém
| Poehled kurzu cenných papíru - PALABA SLANÝ | ||||||||||||||
  Datum | Kurz BCPP [Ke] | Zmina BCPP [%] | Objem BCPP [Ke] | Poeet BCPP [ks] | Kurz RMS [Ke] | Zmina RMS [%] | Objem RMS [Ke] | Poeet RMS [ks] |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.2.1995 | 563.00 | -489.00% | 0 | 0 | 600.00 | -10.00% | 9 600 | 16 | ||||||
| 14.5.1996 | 308.00 | -4.93% | 0 | 0 | 313.00 | -7.00% | 9 460 | 30 | ||||||
| 17.5.1996 | 292.00 | -4.88% | 8 760 | 30 | 315.00 | +2.00% | 9 135 | 29 | ||||||
| 5.3.1996 | 357.00 | -4.54% | 56 049 | 157 | 365.00 | -5.00% | 8 981 | 25 | ||||||
| 26.4.1996 | 401.00 | -4.97% | 72 180 | 180 | 380.00 | +7.00% | 8 955 | 24 | ||||||
| 5.10.1995 | 156.00 | +1.06% | 3 432 | 22 | 170.00 | 0.00% | 8 840 | 52 | ||||||
| 3.11.2000 | 140.60 | +0.35% | 8 689 | 62 | ||||||||||
| 30.5.1995 | 170.00 | 0.00% | 11 900 | 70 | 191.60 | -4.00% | 8 622 | 45 | ||||||
| 12.1.1995 | 0 | 0 | 707.00 | -10.00% | 8 484 | 12 | ||||||||
| 15.4.1996 | 346.00 | +4.84% | 6 920 | 20 | 331.00 | +4.00% | 8 363 | 26 | ||||||
| 10.1.1996 | 282.00 | +0.71% | 255 210 | 905 | 300.00 | -1.00% | 8 289 | 28 | ||||||
| 10.4.1996 | 310.00 | 0.00% | 5 270 | 17 | 300.00 | +2.00% | 8 264 | 27 | ||||||
| 22.5.1996 | 276.00 | 0.00% | 7 176 | 26 | 337.00 | +1.00% | 8 258 | 26 | ||||||
| 5.9.1996 | 190.00 | -4.76% | 4 370 | 23 | 200.00 | -1.00% | 8 153 | 41 | ||||||
| 15.2.1995 | 614.00 | -10.00% | 7 982 | 13 | ||||||||||
| 22.4.1996 | 404.00 | +4.93% | 72 720 | 180 | 315.50 | +5.00% | 7 888 | 25 | ||||||
| 29.1.1996 | 400.00 | 0.00% | 27 200 | 68 | 400.00 | +6.00% | 7 775 | 20 | ||||||
| 17.1.1995 | 765.00 | -413.00% | 38 250 | 50 | 637.00 | -10.00% | 7 644 | 12 | ||||||
| 31.5.1996 | 286.00 | +2.14% | 98 670 | 345 | 262.50 | +2.00% | 7 613 | 29 | ||||||
| 20.1.1995 | 748.00 | -26.00% | 22 440 | 30 | 760.00 | +9.00% | 7 600 | 10 | ||||||
| ||||||||||||||
Okénko BIG EXPERT
Lukáš Hrma, ČSNF SICAV, a.s.
Tomáš Cverna, XTB
Léto bude pro akcie důležité, Evropa vyhlíží volby ve Francii
David Matulay, InvestingFox
Nejhodnotnější společnost v Evropě: Léky na obezitu společnosti Novo Nordisk jsou velmi žádané
Ing. Vladimír Pikora, Ph.D., Dluhopisomat
David Varga, Fintokei
Roman Vykouřil, Wonderinterest Trading s.r.o.
Vydrží koruna i nadále zpevňovat? Odpověď dostaneme brzy, záležet bude na ECB
